CBD for the world

CBD for the world

Surely when talking about medical cannabis you have also heard about CBD, this cannabinoid is largely responsible for the medicinal properties of cannabis, but we go through steps defining and giving context to understand a little more.

 

Our beloved plant has more than 110 cannabinoids, which are those active compounds that belong to the group of terpenophenols and represent more than 40% of the extraction of marijuana. These are responsible for activating the receptors of the human endocannabinoid system (this topic will be developed in another article) and therefore for the pharmacological effects of the plant. They are also called phytocannabinoids because they are exclusive to cannabis production, while endogenous cannabinoids are those produced by humans and some animals.

 

The most famous cannabinoid previously is THC (Tetrahydrocannabinol) responsible for the psychoactive effect of marijuana, although it also has medicinal properties such as analgesic and antispasmodic. CBN, CBG, CBL … etc., the list is extensive and some despite being isolated and identified, few important effects on humans and / or very little research around to determine its benefits in detail.

 

On the contrary, CBD (Cannabidiol) has been extensively studied and with a margin of research to determine in more detail all its benefits. The following healing properties are attributed to CBD and, on the contrary, THC has no psychoactive effect.

  • Analgesic
  • Anti-inflammatory
  • Antiemetic
  • Antipsychotic
  • Antiepileptic
  • Antispasmodic
  • Neuroprotector
  • Regulates blood sugar levels
  • Antibacterial
  • Promotes bone growth
  • Fight insomnia
  • Relieves anxiety
  • Appetite stimulant

 

Depending on the cultivated species, a higher or lower concentration of CBD can be found, usually, without being a rule, finding a higher CBD content means a lower amount of THC, however there are few species and they depend on their care and cultivation, so Even in the extraction of these active components, their concentration and the level of technification with which it is made can vary, since if done domestically, it would be at the mercy of the initial concentration contained in the cultivated species.

 

You want to know more? Attend our symposium on May 12 and 13, 2020 in Bogotá, Colombia and expand your knowledge about the healing power of cannabis.

 

References:

  1. https://geaseeds.com/blog/cbd-cannabidiol/
  2. https://www.royalqueenseeds.es/blog-cbd-el-cannabinoide-mas-desconocido-n52
  3. http://cannabismedicinal.com.ar/historyofcannabis/18.php
CannaCiencia promotes Medicinal Cannabis in the medical, scientific and business agenda of the country.

CannaCiencia promotes Medicinal Cannabis in the medical, scientific and business agenda of the country.

With close to 350 attendees, 24 presentations by experts in medicinal cannabis and a commercial space that gathered brands and enterprises at national and international level, Cannaciencia, the first Cannabis Science Symposium of the Americas is consolidated as the platform to educate, visualize advances scientists, academics, doctors, pharmacists and technologists in this field, and the challenges and opportunities for the development of the cannabis industry in Colombia.

 

The first edition of CannaCiencia leaves a good balance. The participation of world authorities such as Dr. Uma Dhanabalam, expert, activist, defender and educator of the therapeutic use of medicinal cannabis; and Dr. Sue Sisley, who has been working on the investigation of the use of cannabis in the treatment of post-traumatic stress in veterans of war in the United States, had a great reception as a reference of the advances and barriers that currently face in their exercise professional, and education as the first path to destigmatization both in the medical community and in the general imagination.

 

In this context, the educational impact is highlighted as one of the main achievements of the event, especially with the topics related to the analytical laboratory and quality control, where there was a great lack of knowledge in the country. The outstanding participation of Scott Kuzdzal, an expert in toxicology and therapeutic drug monitoring, emphasized the responsibility of the industry in the implementation of effective processes to guarantee the correct labeling and the production of safe and contaminant-free medicinal cannabis.

 

For his part, Joshua Crossney, Founder of jCanna and the Cannabis Science Conference in the USA, presented the advances in academic research, in its commitment to close the gap between analytical sciences and the medical industry of cannabis to help improve quality of the products that patients use.

 

CannaCiencia also made visible the Colombian scientists and the research they are currently carrying out, offering them a platform for discussion, interconnection and search for funding, at a point where it is crucial to promote research for medical, clinical and pharmaceutical development.

 

The context of legalization and regulation of Medicinal Cannabis in Colombia also opened a door for industry experts and investors from countries where the business is already on a journey, which focus on the opportunities and potential of the nascent local industry. The presence of important investors in Cannaciencia such as Tuatara Capital of New York, support the importance of this scenario.

 

In the same way, a new and growing generation of entrepreneurs was identified around the medicinal cannabis industry, eager for ideas, information and alternatives to access capital.

 

“We are facing the challenges of an industry that is at the starting point. The economic impact of the emerging industry worldwide is historic, with compound annual growth rates of up to 34% (CAGR). It requires a huge venture capital education (risk capital) component, clear regulation by the competent financial authorities and inclusion for the Latino community in the emerging industry worldwide, “says Carol Ortega Algarra, CEO of Muisca Capital Group, the first Latin investment management firm, Founder of CannaCiencia and the Network of Cannabis Entrepreneurs of Colombia ”

 

For his part, Ricardo Martinez Executive Director of CannaCiencia and the Network of Cannabis Entrepreneurs of Colombia, says that the 3 most outstanding results of the symposium were: advanced scientific education given to attendees, visualization of Latin American scientists and their findings , derived from research projects, and the visit of multiple investment firms and family offices in North America, Europe and Asia. CannaCiencia is positioned as an international benchmark in science related to Medicinal Cannabis.

 

As a result, in August, the first cycle of training for entrepreneurs linked to the Network of Cannabis Entrepreneurs of Colombia and individuals interested in training will begin, with the first CannaCiencia Workshop, which will include the participation of specialists in cultivation, production, transformation and economic science of medicinal cannabis.